Logo
x

Search

Subscribe Now

Puma Biotechnology

Puma Biotechnology Commences the P-II (ALISCA-Breast1) Study of Alisertib in HR-Positive, HER2-Negative Metastatic Breast Cancer

Puma Biotechnology Commences the P-II (ALISCA-Breast1) Study of Alisertib in HR-Positive, HER2-Negative Metastatic Breast Cancer

  • November 22, 2024
Puma Biotechnology Presents P-II (SUMMIT) Basket Trial Results of Neratinib for EGFR Exon 18-Mutant NSCLC at EORTC/NCI/AACR 2022

Puma Biotechnology Presents P-II (SUMMIT) Basket Trial Results of Neratinib for EGFR Exon 18-Mutant NSCLC at EORTC/NCI/AACR 2022

  • October 28, 2022
Insights+: Key Events of ASCO 2019

Insights+: Key Events of ASCO 2019

  • July 6, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.